FIELD: gynecology. SUBSTANCE: plaster preventing ovulation in women includes and underlying matrix layer containing mixture of 17-deacetylnorhestimate and glue, the latter being effective on pressing and containing one silicone and polyisobutylene and also being adapted for diffusion adhesion to female skin. EFFECT: enabled controlled hormonal therapy. 12 cl, 6 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THREE-PHASE ORAL CONTRACEPTIVE | 1999 |
|
RU2225207C2 |
| INTERRUPTED HORMONE-SUBSTITUTION THERAPY WITH LOW ESTROGEN DOSAGES | 2000 |
|
RU2245713C2 |
| TRANSDERMAL DELIVERY OF LAZOPHOXIPHEN | 2001 |
|
RU2328276C2 |
| AGENT AND METHOD FOR TRANSDERMAL DELIVERY OF OESTROGEN | 2009 |
|
RU2526186C2 |
| METHOD AND PRESSURE-SENSITIVE SYSTEM FOR DELIVERING DRUGS IN TRANSDERMAL WAY | 1992 |
|
RU2124340C1 |
| ADMINISTRATION OF ANDROGENIC STEROIDS TO WOMEN BY NON-ORAL ROUTE | 2000 |
|
RU2234920C2 |
| METHOD FOR ENHANCING OF TESTOSTERONE AND ANALOGOUS STEROID LEVELS IN FEMALES | 2001 |
|
RU2286787C2 |
| ORAL CONTRACEPTIVES FOR PREVENTION PREGNANCY AND REDUCTION OF PREMENSTRUAL SYMPTOMATOLOGY | 2002 |
|
RU2351339C2 |
| STEROID HORMONE PREPARATIONS AND METHOD FOR PRODUCTION THEREOF | 2001 |
|
RU2286155C2 |
| COMPOSITIONS FOR PERSONALIZED CONTRACEPTION | 2018 |
|
RU2796919C2 |
